-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In recent years, with the support of a series of favorable policies, the Chinese medicine sector is showing a good development trend
.
But at the same time, with the successive introduction of policies such as medical insurance fee control, hospital adjustment of the proportion of drugs, and standardization of clinical pathways, the entire Chinese medicine industry has begun to face more and more challenges
.
The Chinese medicine industry has ushered in a major reshuffle (picture source: pharmacy.
com) Among them, take centralized procurement as an example.
At present, local centralized procurement has begun to "start" the trial of traditional Chinese medicine and issued relevant centralized procurement measures
.
Judging from the corporate requirements and post-bid regulations for local centralized procurement of Chinese herbal medicines, the rules have become more and more detailed, and large pharmaceutical companies are inclined to participate; in addition, there is more and higher demand for the quality of Chinese herbal medicine products
.
In this regard, the industry believes that the traditional Chinese medicine industry is expected to usher in a new round of reshuffle in the context of medical reform, regulatory policies and favorable policies
.
Those Chinese medicine companies with weaker strengths and weak innovation and R&D capabilities may be eliminated
.
If they don't want to leave the market, companies can only accelerate their transformation and upgrading, either to expand into the field of innovative medicines such as biomedicine, or to increase the development of traditional Chinese medicine products to prevent the emergence of a single product development dilemma
.
However, for some small and medium-sized enterprises that are not strong enough, analysts also pointed out that if they want to accelerate their transformation, gain more competitiveness in the market, and not be easily eliminated, they must first do a long-term strategic plan and increase the layout.
Under the premise of R&D and clinical trials, ensure product quality and efficacy, while controlling product costs; in addition, measures such as improving planting technology, establishing diversified Chinese medicinal materials planting bases and realizing cold storage of Chinese medicinal materials to reduce natural disasters of Chinese medicinal materials The fluctuations in the quality and output of Chinese medicinal materials have been brought about
.
It is worth noting that in addition to traditional Chinese medicine companies, some people in the industry have pointed out that in the context of a major reshuffle in the traditional Chinese medicine industry, as the traditional Chinese medicine pharmaceutical equipment industry, which is closely related to the traditional Chinese medicine industry, it also needs to actively respond
.
In fact, the production of traditional Chinese medicine is always inseparable from the assistance of pharmaceutical equipment
.
With the accelerating transformation of the Chinese medicine industry and the continuous tightening of supervision, the requirements for Chinese medicine pharmaceutical equipment have become higher and higher
.
At present, in order to better promote the innovation and development of traditional Chinese medicine equipment, a large number of pharmaceutical equipment companies in China have begun to practice their internal skills one after another, striving to produce high-quality, sophisticated, and cutting-edge equipment, staying away from low-level competition, and further helping the Chinese medicine industry to achieve high-quality Direction development
.
For example, a company has developed a color sorter that can perform AI algorithm analysis through the optical path system and the vision system, and can accurately identify the shape and color of the material, and eliminate unnecessary materials
.
On the whole, with the advent of the era of intelligent automation, the pharmaceutical equipment industry is actually accelerating the development of new products in the direction of intelligent automation in order to further improve product performance
.
For example, through continuous technological advancement, fully automatic Chinese medicine pill making machines are emerging one after another in the industry
.
The fully automatic Chinese medicine pill making machine newly launched by an enterprise has the characteristics of round pill shape, accurate dosage, fast disintegration, smooth delivery, no shed material, stable transmission, simple operation and low failure rate
.
In short, in order to better promote the development of the domestic traditional Chinese medicine industry, the country and even localities will put forward higher requirements and more standards for its production, storage, and transportation links
.
For manufacturers, it is necessary to fulfill the main responsibilities and related obligations of the whole life cycle of drugs, strengthen management and control in the production and management process, and ensure the quality and safety of traditional Chinese medicine formula granules, so as to help companies usher in more development opportunities in the future
.
For pharmaceutical machinery companies, it will be their duty to use modern science and technology to promote the modernization of traditional Chinese medicine and to open up new paths for the inheritance, innovation and development of traditional Chinese medicine
.
.
But at the same time, with the successive introduction of policies such as medical insurance fee control, hospital adjustment of the proportion of drugs, and standardization of clinical pathways, the entire Chinese medicine industry has begun to face more and more challenges
.
The Chinese medicine industry has ushered in a major reshuffle (picture source: pharmacy.
com) Among them, take centralized procurement as an example.
At present, local centralized procurement has begun to "start" the trial of traditional Chinese medicine and issued relevant centralized procurement measures
.
Judging from the corporate requirements and post-bid regulations for local centralized procurement of Chinese herbal medicines, the rules have become more and more detailed, and large pharmaceutical companies are inclined to participate; in addition, there is more and higher demand for the quality of Chinese herbal medicine products
.
In this regard, the industry believes that the traditional Chinese medicine industry is expected to usher in a new round of reshuffle in the context of medical reform, regulatory policies and favorable policies
.
Those Chinese medicine companies with weaker strengths and weak innovation and R&D capabilities may be eliminated
.
If they don't want to leave the market, companies can only accelerate their transformation and upgrading, either to expand into the field of innovative medicines such as biomedicine, or to increase the development of traditional Chinese medicine products to prevent the emergence of a single product development dilemma
.
However, for some small and medium-sized enterprises that are not strong enough, analysts also pointed out that if they want to accelerate their transformation, gain more competitiveness in the market, and not be easily eliminated, they must first do a long-term strategic plan and increase the layout.
Under the premise of R&D and clinical trials, ensure product quality and efficacy, while controlling product costs; in addition, measures such as improving planting technology, establishing diversified Chinese medicinal materials planting bases and realizing cold storage of Chinese medicinal materials to reduce natural disasters of Chinese medicinal materials The fluctuations in the quality and output of Chinese medicinal materials have been brought about
.
It is worth noting that in addition to traditional Chinese medicine companies, some people in the industry have pointed out that in the context of a major reshuffle in the traditional Chinese medicine industry, as the traditional Chinese medicine pharmaceutical equipment industry, which is closely related to the traditional Chinese medicine industry, it also needs to actively respond
.
In fact, the production of traditional Chinese medicine is always inseparable from the assistance of pharmaceutical equipment
.
With the accelerating transformation of the Chinese medicine industry and the continuous tightening of supervision, the requirements for Chinese medicine pharmaceutical equipment have become higher and higher
.
At present, in order to better promote the innovation and development of traditional Chinese medicine equipment, a large number of pharmaceutical equipment companies in China have begun to practice their internal skills one after another, striving to produce high-quality, sophisticated, and cutting-edge equipment, staying away from low-level competition, and further helping the Chinese medicine industry to achieve high-quality Direction development
.
For example, a company has developed a color sorter that can perform AI algorithm analysis through the optical path system and the vision system, and can accurately identify the shape and color of the material, and eliminate unnecessary materials
.
On the whole, with the advent of the era of intelligent automation, the pharmaceutical equipment industry is actually accelerating the development of new products in the direction of intelligent automation in order to further improve product performance
.
For example, through continuous technological advancement, fully automatic Chinese medicine pill making machines are emerging one after another in the industry
.
The fully automatic Chinese medicine pill making machine newly launched by an enterprise has the characteristics of round pill shape, accurate dosage, fast disintegration, smooth delivery, no shed material, stable transmission, simple operation and low failure rate
.
In short, in order to better promote the development of the domestic traditional Chinese medicine industry, the country and even localities will put forward higher requirements and more standards for its production, storage, and transportation links
.
For manufacturers, it is necessary to fulfill the main responsibilities and related obligations of the whole life cycle of drugs, strengthen management and control in the production and management process, and ensure the quality and safety of traditional Chinese medicine formula granules, so as to help companies usher in more development opportunities in the future
.
For pharmaceutical machinery companies, it will be their duty to use modern science and technology to promote the modernization of traditional Chinese medicine and to open up new paths for the inheritance, innovation and development of traditional Chinese medicine
.